comparemela.com
Home
Live Updates
Lumos Pharma, Inc. (NASDAQ:LUMO) Q4 2022 Earnings Call Transcript : comparemela.com
Lumos Pharma, Inc. (NASDAQ:LUMO) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to Lumos Pharma's 2022 Financial Results Conference Call. We'll now turn the call over to Lisa Miller, Senior Director of Investor Relations.
Related Keywords
Chile ,
Russia ,
Buenos Aires ,
Distrito Federal ,
Argentina ,
Massachusetts ,
United States ,
Ukraine ,
Fernando Cassorla ,
David Karpf ,
Laura Dichtel ,
Charles Duncan ,
Erick Hawkins ,
John Mckew ,
Lori Lawley ,
Andrew Dauber ,
Peter Rosenthal ,
Richard Hawkins ,
Lisa Miller ,
Lumos Pharma ,
University Of Chile ,
Most Valuable Furniture Companies ,
Health Photo ,
Children National Hospital ,
International Meeting Of Pediatric Endocrinology ,
Lumos Pharma Inc ,
Nasdaq ,
Call Transcript March ,
Results Conference ,
Senior Director ,
Chief Scientific Officer ,
Chief Medical Officer ,
Idiopathic Pediatric Growth Hormone Deficiency ,
Predictive Enrichment Marker ,
National Hospital ,
Pediatric Endocrinology ,
Massachusetts General Hospital ,
Nonalcoholic Fatty Liver Disease ,
Massachusetts General ,
Compactable Oral Formulations ,
Idiopathic Short Stature ,
Prader Willi Syndrome ,
Valuable Furniture ,
comparemela.com © 2020. All Rights Reserved.